Moreover, NAP is currently being studied in tumor therapy given its ability to induce TLR2 transcripts and promote peripheral blood mononuclear cells of cancer patients to secrete IFN-γ and IL-12 (49–53). This evidence concerns the gene TLR2 and neoplasm.